Newsflash

LIFT Cancer Trial Starting in China
A new clinical trial based on Dr. Zheng Cui's granulocyte technology is starting at Beijing's 304 Hospital. Go to The LIFT Cancer Treatment Trial Site for more information.
Pancreatic Cancer Treatment Print

Pancreatic Cancer, as its name implies, starts in the pancreas. The prognosis of pancreatic cancer is generally regarded as poor, less than 5% of those diagnosed live more than five years after the original diagnosis, and complete remission still extremely rare.

Traditional treatments
The traditional treatments for pancreatic cancer include surgery, chemotherapy and radiotherapy.

Cutting-edge therapies available in China Cancer Centers (CCC) for pancreatic cancer may consist of:
For early stage pancreatic cancer
   Surgery
   CIK-DC immunotherapy
Features:
    1. Better efficacy, for better control of the development of pancreatic cancer.
    2. No toxicity or side effects. Life quality improved.
    3. No damage to natural immune system. Restore the natural ability against cancer.
    4. Survival time prolonged.


For advanced pancreatic cancer:
   HIFU
   Gene therapy
   Antiangionesis therapy
   Gentle chemotherapy
   CIK-DC immunotherapy
Features:
    1. HIFU offers a new option for patients can’t afford a traditional surgery.
    2. Mild chemotherapy offers a lower toxicity and fewer side effects than the regular chemotherapy with the same efficacy as the standard.
    3. CIK-DC cell immunotherapy offers an improved life quality and prolong survival time by restoring the natural immunity against cancer.

 

Read more about case study

Pancreatic Cancer liver metastasis - 60 yr -Australian - Sep 2006

Last Updated on Tuesday, 18 August 2009 12:11